Home// - Pneumonia Drug for COVID19 Treatment
Are you sure you want to exit?
Any unsave changes will be lost.
Pneumonia Drug for COVID19 Treatment
BioAegis
Category
Laboratory
Country
United States of America (USA), North America
Description
BioAegis Therapeutics is using its lead product for severe pneumonia, rhu-pGSN as an otion for treatment for COVID19.